Meeting
2024 ASCO Annual Meeting
Dynamics of circulating cytokines and chemokines during and after tumor-infiltrating lymphocyte cell therapy with lifileucel in advanced melanoma patients.
Authors
Rongsu Qi
Iovance Biotherapeutics, Inc., San Carlos, CA
Rongsu Qi , Amod Sarnaik , John M. Kirkwood , James Larkin , Jeffrey S. Weber , Michelle Blaskovich , Kranthi Kunkalla , Rana Fiaz , Giri Sulur , Jeffrey Chou , Hequn Yin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Other Melanoma/Skin Cancers
Clinical Trial Registration Number
NCT02360579
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 9594)
DOI
10.1200/JCO.2024.42.16_suppl.9594
Abstract #
9594
Poster Bd #
378
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Safety and efficacy of cryopreserved autologous tumor infiltrating lymphocyte therapy (LN-144, lifileucel) in advanced metastatic melanoma patients who progressed on multiple prior therapies including anti-PD-1.
First Author: Amod Sarnaik
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Single-cell cytokine profiling of tumor-infiltrating T cells to measure patient responses to anti-PD-1 therapy.
First Author: Sean Mackay
Poster
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Safety and efficacy of cryopreserved autologous tumor infiltrating lymphocyte therapy (LN-144, lifileucel) in advanced metastatic melanoma patients previously treated with at least one prior systemic therapy.
First Author: Amod Sarnaik
Poster
2023 ASCO Annual Meeting
Identification of cytokines associated with response and cytokine release syndrome: Analysis of MagnetisMM-3 cohort A.
First Author: HANG QUACH